DK181389D0 - Injektionsformer af gyraseinhibitorer - Google Patents

Injektionsformer af gyraseinhibitorer

Info

Publication number: DK181389D0
Authority: DK; Denmark
Prior art keywords: injection forms; gyrase inhibitors; gyrase; inhibitors; injection
Prior art date: 1988-04-15

Application number

DK181389A

Other languages

English (en)

Other versions

DK169772B1 (da

DK181389A (da

Inventor

Norbert Poellinger

Peter Serno

Wolfram Hofmann

Dieter Beermann

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-04-15

Filing date

1989-04-14

Publication date

1989-04-14

1989-04-14 Application filed by Bayer Ag filed Critical Bayer Ag

1989-04-14 Publication of DK181389D0 publication Critical patent/DK181389D0/da

1989-10-31 Publication of DK181389A publication Critical patent/DK181389A/da

1995-02-27 Application granted granted Critical

1995-02-27 Publication of DK169772B1 publication Critical patent/DK169772B1/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Quinoline Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK181389A 1988-04-15 1989-04-14 Intramuskulære injektionsformuleringer af gyraseinhibitorer og deres fremstilling DK169772B1 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DE3812508		1988-04-15
DE3812508		1988-04-15
DE3902079A DE3902079A1 (de)	1988-04-15	1989-01-25	I.m. injektionsformen von gyrase-inhibitoren
DE3902079		1989-01-25

Publications (3)

Publication Number	Publication Date
DK181389D0 true DK181389D0 (da)	1989-04-14
DK181389A DK181389A (da)	1989-10-31
DK169772B1 DK169772B1 (da)	1995-02-27

Family

ID=25866993

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK181389A DK169772B1 (da)	1988-04-15	1989-04-14	Intramuskulære injektionsformuleringer af gyraseinhibitorer og deres fremstilling

Country Status (15)

Country	Link
US (1)	US5023257A (da)
EP (1)	EP0337231B1 (da)
JP (1)	JPH01316321A (da)
KR (1)	KR900015736A (da)
CN (1)	CN1037272A (da)
AU (1)	AU610380B2 (da)
CA (1)	CA1336822C (da)
DE (2)	DE3902079A1 (da)
DK (1)	DK169772B1 (da)
ES (1)	ES2038359T3 (da)
GR (1)	GR3005415T3 (da)
HU (1)	HUT54048A (da)
IE (1)	IE60407B1 (da)
IL (1)	IL89928A (da)
NZ (1)	NZ228708A (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2655545B1 (fr) *	1989-12-11	1994-06-10	Rhone Poulenc Sante	Nouvelle application therapeutique des derives des fluoroquinolones.
FR2665635A1 (fr) *	1990-08-10	1992-02-14	Merck Sharp & Dohme	Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
US5420124A (en) *	1994-01-12	1995-05-30	Kim; Young S.	Stable, painless piroxicam potassium injectable composition
US5843930A (en) *	1995-06-06	1998-12-01	Bayer Corporation	Method of treating otitis with ciprofloxacin-hydrocortisone suspension
IL120317A (en) *	1995-06-06	2000-08-13	Bayer Ag	Ciprofloxacin-hydrocortisone suspension
HU227918B1 (en) *	1995-12-21	2012-06-28	Pfizer	Injectable quinolone formulations
IN186245B (da)	1997-09-19	2001-07-14	Ranbaxy Lab Ltd
ID21415A (id)	1997-12-05	1999-06-10	Upjohn Co	Senyawa-senyawa antibiotik magnesium quinolon
AU2001232809A1 (en) *	2000-01-18	2001-07-31	Vertex Pharmaceuticals Incorporated	Gyrase inhibitors and uses thereof
US20030170858A1 (en) *	2001-01-16	2003-09-11	Paul Charifson	Gyrase inhibitors and uses thereof
NZ534746A (en) *	2002-03-12	2006-06-30	Bristol Myers Squibb Co	Palatable oral suspension and method
CA2536429C (en)	2003-09-10	2012-02-14	Kyorin Pharmaceutical Co., Ltd.	7-(4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative
US20070196398A1 (en) *	2006-02-17	2007-08-23	Murthy Yerramilli V S	Fluoroquinolone fatty acid salt compositions
US8222407B2 (en)	2007-05-24	2012-07-17	Kyorin Pharmaceutical Co., Ltd.	Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
CN102716072B (zh) *	2012-06-13	2014-06-18	广州南新制药有限公司	一种乳酸环丙沙星氯化钠注射液的制备方法
US9316635B2 (en) *	2013-03-15	2016-04-19	Iris International, Inc.	Sheath fluid systems and methods for particle analysis in blood samples
KR101802626B1 (ko)	2013-03-15	2017-11-28	아이리스 인터내셔널 인크.	염색 및 샘플 처리를 위한 방법 및 조성물
US9393243B1 (en)	2015-07-14	2016-07-19	Nilesh Parikh	Topical Ciprofloxacin compositions
ITUB20155193A1 (it) *	2015-11-03	2017-05-03	Italfarmaco Spa	Sospensioni orali di Givinostat fisicamente e chimicamente stabili

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE564864A (da) *
US4181721A (en) *	1975-10-27	1980-01-01	Schering Aktiengesellschaft	Depot preparations in an oily, unsaturated solution for intramuscular injection
DE3033157A1 (de) *	1980-09-03	1982-04-01	Bayer Ag, 5090 Leverkusen	7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4620007A (en) *	1980-09-03	1986-10-28	Bayer Aktiengesellschaft	6-fluoro-7-chloro-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
US4670444B1 (en) *	1980-09-03	1999-02-09	Bayer Ag	and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3306771A1 (de) *	1983-02-25	1984-08-30	Bayer Ag, 5090 Leverkusen	Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3306772A1 (de) *	1983-02-25	1984-08-30	Bayer Ag, 5090 Leverkusen	Chinolonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3324192A1 (de) *	1983-07-05	1985-01-17	Troponwerke Gmbh & Co Kg	Depot-antiphlogistika
DE3333719A1 (de) *	1983-09-17	1985-04-04	Bayer Ag	Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
DE3517709A1 (de) *	1985-01-05	1986-07-10	Bayer Ag	Basische zubereitungen von chinoloncarbonsaeuren
DE3522406A1 (de) *	1985-06-22	1987-01-02	Bayer Ag	Verfahren zur herstellung von 1,8-verbrueckten 4-chinolon-3-carbonsaeuren
DE3608745A1 (de) *	1985-07-24	1987-01-29	Bayer Ag	Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin
US4816247A (en) *	1985-09-11	1989-03-28	American Cyanamid Company	Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
IN166416B (da) *	1985-09-18	1990-05-05	Pfizer
DE3537761A1 (de) *	1985-10-24	1987-04-30	Bayer Ag	Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE3542972A1 (de) *	1985-12-05	1987-06-11	Merck Patent Gmbh	Pharmakadepot
DE3705621C2 (de) *	1986-02-25	1997-01-09	Otsuka Pharma Co Ltd	Heterocyclisch substituierte Chinoloncarbonsäurederivate
DE3623757A1 (de) *	1986-07-15	1988-01-21	Bayer Ag	Neue 1,8-verbrueckte 4-chinoloncarbonsaeuren und diese enthaltende arzneimittel
IL80459A (en) *	1986-10-30	1991-04-15	Abic Ltd	Water-soluble adduct of norfloxacin and nicotinic acid
DE3713672A1 (de) *	1987-04-24	1988-11-17	Bayer Ag	Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US4780468A (en) *	1987-08-07	1988-10-25	Warner-Lambert Company	8-trifluoromethyl quinolones as antibacterial agents
US4803205A (en) *	1987-08-07	1989-02-07	Warner-Lambert Company	Quinolones as antibacterial agents
US4933335A (en) *	1987-08-07	1990-06-12	Warner-Lambert Company	Quinolones as antibacterial agents
US4839355A (en) *	1987-09-09	1989-06-13	Sterling Drug Inc.	Tricyclic-pyridinylquinoline compounds, their preparation and use

1989
- 1989-01-25 DE DE3902079A patent/DE3902079A1/de not_active Withdrawn
- 1989-04-03 ES ES89105795T patent/ES2038359T3/es not_active Expired - Lifetime
- 1989-04-03 DE DE8989105795T patent/DE58901663D1/de not_active Expired - Lifetime
- 1989-04-03 EP EP89105795A patent/EP0337231B1/de not_active Expired - Lifetime
- 1989-04-12 NZ NZ228708A patent/NZ228708A/en unknown
- 1989-04-12 JP JP1090887A patent/JPH01316321A/ja active Pending
- 1989-04-12 AU AU32753/89A patent/AU610380B2/en not_active Ceased
- 1989-04-12 IL IL89928A patent/IL89928A/xx not_active IP Right Cessation
- 1989-04-13 CA CA000596557A patent/CA1336822C/en not_active Expired - Fee Related
- 1989-04-14 KR KR1019890004958A patent/KR900015736A/ko not_active Ceased
- 1989-04-14 DK DK181389A patent/DK169772B1/da not_active IP Right Cessation
- 1989-04-14 IE IE120189A patent/IE60407B1/en not_active IP Right Cessation
- 1989-04-14 HU HU891867A patent/HUT54048A/hu unknown
- 1989-04-15 CN CN89102284A patent/CN1037272A/zh active Pending
1990
- 1990-07-06 US US07/549,664 patent/US5023257A/en not_active Expired - Fee Related
1992
- 1992-08-11 GR GR920401742T patent/GR3005415T3/el unknown

Also Published As

Publication number	Publication date
IE60407B1 (en)	1994-07-13
KR900015736A (ko)	1990-11-10
JPH01316321A (ja)	1989-12-21
CA1336822C (en)	1995-08-29
IL89928A (en)	1993-05-13
NZ228708A (en)	1992-06-25
DK169772B1 (da)	1995-02-27
AU3275389A (en)	1989-10-19
GR3005415T3 (da)	1993-05-24
EP0337231A2 (de)	1989-10-18
US5023257A (en)	1991-06-11
HUT54048A (en)	1991-01-28
AU610380B2 (en)	1991-05-16
EP0337231B1 (de)	1992-06-17
IL89928A0 (en)	1989-12-15
CN1037272A (zh)	1989-11-22
EP0337231A3 (en)	1990-01-17
IE891201L (en)	1989-10-15
DK181389A (da)	1989-10-31
ES2038359T3 (es)	1995-04-01
DE3902079A1 (de)	1989-10-26
DE58901663D1 (de)	1992-07-23

Publication	Publication Date	Title
DK181389D0 (da)	1989-04-14	Injektionsformer af gyraseinhibitorer
DK70491D0 (da)	1991-04-18	Heterocyklisk renininhibitorer
FI933303L (fi)	1993-08-31	Adenosinkinasinhibitorer
FI923119A7 (fi)	1993-01-12	Krutdriven montageanordning med magasin foer faestelement
DK372987D0 (da)	1987-07-17	Anordning til at forhindre uvedkommende anvendelse af databaerere
BR8907457A (pt)	1991-04-02	Inibidores de interleucina-1
DK430285A (da)	1986-03-25	N-substituerede derivater af 2-(pyridylalkensulfinyl)-benzimidazoler samt disses fremstilling
MX9100998A (es)	1992-05-04	Novedosos inhibidores de escualen sintetasa
DK608888A (da)	1989-05-03	Anvendelse af polysaccharidderivater
DK372089D0 (da)	1989-07-27	Anvendelse af isoquinolinderivater
DK273089A (da)	1989-12-07	Anvendelse af peptidderivater
DK293088A (da)	1988-12-02	Inhibitorer af dopamin-beta-hydroxylase
FI101796B1 (fi)	1998-08-31	Uusia -glukosidaasi-inhibiittoreita
DK270988D0 (da)	1988-05-18	Nitrogenholdige derivater af epipodophyllotoxinglucosider
DK104389D0 (da)	1989-03-03	Anvendelse af imidazolderivater
DK104489D0 (da)	1989-03-03	Anvendelse af triazolderivater
DK316589D0 (da)	1989-06-26	Substituerede azacyclohexylderivater af rifamyciner
DK562289A (da)	1990-05-12	Anvendelse af somatostatiner
DK299489A (da)	1989-06-16	Potensering af ace-inhibitorers antihypertensive virkning
DK69489A (da)	1989-08-17	Aspartattranscarbamylase-inhibitorer
DK120689D0 (da)	1989-03-13	Komplekser af selen- og tellurderivater
DK664789A (da)	1990-06-29	Fremgangsmaade til hydroaminering af olefiner
DK326789A (da)	1990-01-02	Fremstilling af homonojirimycin-derivater
FI893162A7 (fi)	1989-12-29	19-hydroksylaasin inhibiittoreina käyttökelpoisia 19-fluori- tai syano- 21-hydroksiprogesteronin johdannaisia
FI896239A7 (fi)	1990-06-28	Reniini-inhibiittoreita

Legal Events

Date	Code	Title	Description
1995-02-27	B1	Patent granted (law 1993)
2002-12-02	PBP	Patent lapsed